181 related articles for article (PubMed ID: 36346691)
1. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.
Tantawy SI; Sarkar A; Hubner S; Tan Z; Wierda WG; Eldeib A; Zhang S; Kornblau S; Gandhi V
Clin Cancer Res; 2023 Jan; 29(2):446-457. PubMed ID: 36346691
[TBL] [Abstract][Full Text] [Related]
2. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
[TBL] [Abstract][Full Text] [Related]
3. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.
Yan J; Zhong N; Liu G; Chen K; Liu X; Su L; Singhal S
Cell Death Dis; 2014 Jul; 5(7):e1316. PubMed ID: 24991768
[TBL] [Abstract][Full Text] [Related]
4. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer.
Nakajima W; Hicks MA; Tanaka N; Krystal GW; Harada H
Cell Death Dis; 2014 Feb; 5(2):e1052. PubMed ID: 24525728
[TBL] [Abstract][Full Text] [Related]
5. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
[TBL] [Abstract][Full Text] [Related]
6. AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia.
Yi X; Sarkar A; Kismali G; Aslan B; Ayres M; Iles LR; Keating MJ; Wierda WG; Long JP; Bertilaccio MTS; Gandhi V
Clin Cancer Res; 2020 Jul; 26(14):3856-3867. PubMed ID: 31937611
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1.
Pang X; Zhang J; Lopez H; Wang Y; Li W; O'Neill KL; Evans JJ; George NM; Long J; Chen Y; Luo X
J Biol Chem; 2014 Jun; 289(25):17802-11. PubMed ID: 24811167
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
Trivigno D; Essmann F; Huber SM; Rudner J
Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
[TBL] [Abstract][Full Text] [Related]
9. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
[TBL] [Abstract][Full Text] [Related]
10. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.
Inoue S; Riley J; Gant TW; Dyer MJ; Cohen GM
Leukemia; 2007 Aug; 21(8):1773-82. PubMed ID: 17525724
[TBL] [Abstract][Full Text] [Related]
12. Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70.
Stankiewicz AR; Livingstone AM; Mohseni N; Mosser DD
Cell Death Differ; 2009 Apr; 16(4):638-47. PubMed ID: 19148187
[TBL] [Abstract][Full Text] [Related]
13. Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability.
Tantawy SI; Timofeeva N; Hernandez A; Sarkar A; Gandhi V
Oncotarget; 2023 Jun; 14():653-655. PubMed ID: 37343064
[No Abstract] [Full Text] [Related]
14. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection.
Hallaert DY; Spijker R; Jak M; Derks IA; Alves NL; Wensveen FM; de Boer JP; de Jong D; Green SR; van Oers MH; Eldering E
Cell Death Differ; 2007 Nov; 14(11):1958-67. PubMed ID: 17703234
[TBL] [Abstract][Full Text] [Related]
15. The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.
Wang B; Ni Z; Dai X; Qin L; Li X; Xu L; Lian J; He F
Mol Cancer; 2014 Apr; 13():98. PubMed ID: 24779770
[TBL] [Abstract][Full Text] [Related]
16. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.
Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW
Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046
[TBL] [Abstract][Full Text] [Related]
17. Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells.
Pervin S; Tran A; Tran L; Urman R; Braga M; Chaudhuri G; Singh R
Br J Cancer; 2011 Jul; 105(3):428-37. PubMed ID: 21730980
[TBL] [Abstract][Full Text] [Related]
18. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.
Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C
Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
20. Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.
Chen LS; Redkar S; Bearss D; Wierda WG; Gandhi V
Blood; 2009 Nov; 114(19):4150-7. PubMed ID: 19734450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
